Our Consortium h1 >
Welcome To BBDC
Baylor College of Medicine was selected by the National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institute of Dental and Craniofacial Research, National Center for Advancing Translational Sciences, and National Institute of Child Health and Human Development) to lead the Brittle Bone Disorders Rare Disease Clinical Research Consortium, a multi–center initiative that focuses on understanding and providing better treatment options for rare diseases characterized by bone fragility and fractures.
The consortium is partnering with the Osteogenesis Imperfecta Foundation, based in Gaithersburg, Maryland, to train a broad spectrum of health care providers in the diagnosis and treatment of osteogenesis imperfecta (OI). The Osteogenesis Imperfecta Foundation is the only voluntary national health organization dedicated to helping people cope with the problems associated with OI.